Literature DB >> 24802908

Prognostic factors and outcome of spermatic cord sarcoma.

Stefano Radaelli1, Anant Desai, James Hodson, Chiara Colombo, Keith Roberts, David Gourevitch, Alessandro Gronchi.   

Abstract

PURPOSE: To evaluate management and outcome in a large series of patients with spermatic cord sarcomas (SCS), a rare malignancy.
METHODS: Eighty-two patients with localized SCS treated at two dedicated sarcoma units between 1992 and 2013 were included. Disease-specific survival (DSS) and crude cumulative incidence of local recurrence and distant metastases (DM) were estimated by Kaplan-Meier plots and log rank tests.
RESULTS: Median follow-up was 33 months (interquartile range 13-72 months). Sixty-one patients presented with primary disease. Liposarcoma was the most common histotype, but surprisingly, 37 % of tumors were of high grade. Seventeen patients (21 %) received radiotherapy and 12 patients (15 %) chemotherapy. Five-year DSS for the whole series was 92 % [95 % confidence interval (CI) 83-97]. Five-year rates of local recurrence and DM were 26 % (95 % CI 15-42) and 24 % (95 % CI 15-38), respectively. Tumor grade was found to be a significant predictor of both DSS and DM (both p < 0.001). Quality of surgical margins was proved to affect the local outcome (p = 0.025), while the rates of distant metastases were found to differ significantly by histology (p = 0.010). Exclusively in the liposarcoma subgroup, quality of surgical margins was also directly associated with DSS (p = 0.043).
CONCLUSIONS: Wide excision of the tumor is critical for cure, especially in the liposarcoma subgroup. The role of radiotherapy and chemotherapy is not established.

Entities:  

Mesh:

Year:  2014        PMID: 24802908     DOI: 10.1245/s10434-014-3751-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Multidisciplinary approach to giant paratesticular liposarcoma.

Authors:  Raquel Sopeña-Sutil; Francesco Silan; Maria Teresa Butron-Vila; Felix Guerrero-Ramos; Emilio Lagaron-Comba; Juan Passas-Martinez
Journal:  Can Urol Assoc J       Date:  2016-09-13       Impact factor: 1.862

2.  Intrascrotal dedifferentiated leiomyosarcoma originating from dartos muscle.

Authors:  Taro Teshima; Sayuri Takahashi; Shoichi Nagamoto; Hideyo Miyazaki; Tohru Nakagawa; Tetsuya Fujimura; Hiroshi Fukuhara; Haruki Kume; Yukio Homma
Journal:  Case Rep Urol       Date:  2014-12-11

3.  Dedifferentiated Liposarcoma in the Spermatic Cord Finally Diagnosed at 7th Resection of Recurrence: A Case Report and Bibliographic Consideration.

Authors:  Kento Morozumi; Yoshihide Kawasaki; Yasuhiro Kaiho; Naoki Kawamorita; Fumiyoshi Fujishima; Mika Watanabe; Yoichi Arai
Journal:  Case Rep Oncol       Date:  2017-08-09

4.  Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience.

Authors:  Massimo Iafrate; Giovanni Motterle; Carlotta Zaborra; Niccolò Leone; Tommaso Prayer-Galetti; Filiberto Zattoni; Andrea Guttilla; Rocco Cappellesso; Angelo Paolo Dei Tos; Carlo Riccardo Rossi; Paolo Del Fiore; Marco Rastrelli; Simone Mocellin
Journal:  Front Surg       Date:  2020-11-17

5.  Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.

Authors:  Rei Kamitani; Kazuhiro Matsumoto; Toshikazu Takeda; Ryuichi Mizuno; Mototsugu Oya
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

6.  Liposarcoma of the Spermatic Cord: Impact of Final Surgical Intervention--An Institutional Experience.

Authors:  R Bachmann; J Rolinger; P Girotti; H G Kopp; K Heissner; B Amend; A Königsrainer; R Ladurner
Journal:  Int J Surg Oncol       Date:  2016-04-14

7.  Identifying Patterns of Failure and Risk Factors for Recurrence in Patients of Paratesticular Sarcomas: Protocol of a Systematic Review and Meta-Analysis.

Authors:  Anil Gupta; Rashi Kulshrestha; Kamal Kishore; Oliver Micke; Rishabh Kumar; Kanika Garg; Dayanand Sharma; Rambha Pandey
Journal:  Int J Surg Protoc       Date:  2021-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.